Effects of metyrapone treatment on cardio-metabolic risk and chronobiology in patients with mild autonomous cortisol secretion
Dauer: 48 Monate, Fördersumme: € 997.688
Persistent Platelet-Monocyte CrossTalk Underlies Failure to Resolve Inflammation and Symptoms in ME/CFS
Dauer: 6 Monate, Fördersumme: € 35.860
Cell-Free DNA Liquid Biopsies for Precision Cardiovascular Medicine
Dauer: 48 Monate, Fördersumme: € 999.285
Engineering enhanced microbiome function using synthetic ecology
Dauer: 48 Monate, Fördersumme: € 897.156
The impact of mast cell activation on epithelial and endothelial barrier dysregulation in post-infectious ME/CFS
Dauer: 15 Monate, Fördersumme: € 99.992
Exploring the Glycome: Identifying Glycosylation-Related Biomarkers for severity stratification in Chronic Fatigue Syndrome
Dauer: 14 Monate, Fördersumme: € 99.946